Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Rimegepant (Nurtec ODT) for Acute Treatment of Migraine.

< BACK TO ARCHIVE


Papers: 29 Aug 2020 - 4 Sep 2020


Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 Sep 01


JAMA


http://www.ncbi.nlm.nih.gov/pubmed/32870296?dopt=Abstract


324


9

Rimegepant (Nurtec ODT) for Acute Treatment of Migraine.

Authors

Rimegepant (Nurtec ODT) for Acute Treatment of Migraine.
JAMA. 2020 Sep 01; 324(9):890-891.
PMID: 32870296.
Read This Paper